Treating human promyelocytic leukemia with Green tea: Epigallocatechin 3-Gallate (EGCG), the major component of Green Tea, induces apoptosis and necrosis via down regulation of its target gene, 18/March/2014, 12.06 pm

Treating human leukemia with a Diabetic pill: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppresses the expression of a proto-oncogene mixed-lineage-AF4 via up regulation of its target gene, 18/March/2014, 12.07 am
March 17, 2014
Treating myocardial ischaemia/reperfusion injury with Green tea: Epigallocatechin 3-Gallate (EGCG), the major component of Green Tea, protects against ischemia/reperfusion injury via down regulation of its target gene, 18/March/2014, 12.17 pm
March 18, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Treating human promyelocytic leukemia with Green tea: Epigallocatechin 3-Gallate (EGCG), the major component of Green Tea, induces apoptosis  and necrosis via down regulation of its target gene, 18/March/2014, 12.05 pm,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.